Cullen/Frost Bankers’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,329
Closed -$54K 1420
2025
Q4
$54K Buy
+1,329
New +$57.8K ﹤0.01% 782
2024
Q3
Sell
-22
Closed -$1.52K 1249
2024
Q2
$1.52K Hold
22
﹤0.01% 1146
2024
Q1
$1.76K Hold
22
﹤0.01% 948
2023
Q4
$2.41K Hold
22
﹤0.01% 932
2023
Q3
$2.22K Hold
22
﹤0.01% 1055
2023
Q2
$2.99K Buy
+22
New +$2.69K ﹤0.01% 1020
2021
Q4
Sell
-314
Closed -$41K 1211
2021
Q3
$41K Hold
314
﹤0.01% 811
2021
Q2
$43K Buy
+314
New +$43K ﹤0.01% 811
2019
Q3
Sell
-72
Closed -$6K 1019
2019
Q2
$6K Buy
+72
New +$5.92K ﹤0.01% 902

Other funds holding CNMD

Cullen/Frost Bankers's CNMD Position: Q1 2026 in Review

Cullen/Frost Bankers sold out of CONMED (CNMD) in Q1 2026, closing a stake of 1,329 shares — an estimated $54K sold.

Cullen/Frost Bankers first reported a position in CNMD in Q2 2019 and held it in 9 quarters. The position peaked at $54K in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Cullen/Frost Bankers reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 1,329 CONMED shares in Q1 2026, an estimated $54K.
  • Cullen/Frost Bankers first reported a position in CONMED in Q2 2019 and held it in 9 quarters.
  • Cullen/Frost Bankers's CONMED position peaked at $54K in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.